Improving HPV vaccination and cervical cancer screening in Nigeria through community engagement
Actions for Collaborative Community Engaged Strategies for HPV (ACCESS-HPV)
This study is all about helping young girls and women in Nigeria get the HPV vaccine and make cervical cancer screening easier by using the strong bond between mothers and daughters to create supportive community messages.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10910920 on NIH RePORTER |
What this research studies
This research focuses on increasing the uptake of HPV vaccination for young girls aged 9-26 and self-collection for cervical cancer screening among women aged 30-49 in Nigeria. By leveraging the influence of mother-daughter relationships, the study aims to develop culturally relevant strategies that encourage participation in HPV prevention efforts. The approach includes participatory crowdsourcing to gather local insights and messages that resonate with the community, ultimately aiming to reduce the burden of cervical cancer. The project seeks to address barriers to vaccination and screening through targeted community engagement.
Who could benefit from this research
Good fit: Ideal candidates for this research include young girls aged 9-26 for vaccination and women aged 30-49 for cervical cancer screening, particularly those living in Nigeria.
Not a fit: Patients outside the specified age ranges or those not residing in Nigeria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce cervical cancer rates in Nigeria by improving vaccination and screening uptake.
How similar studies have performed: Previous research has shown success in community-engaged strategies for health interventions, indicating potential for this approach to be effective.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Iwelunmor, Juliet — Washington University
- Study coordinator: Iwelunmor, Juliet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.